Filtered By:
Condition: Atrial Fibrillation
Management: Economics
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 62 results found since Jan 2013.
Cost-effectiveness of targeted screening for the identification of patients with atrial fibrillation: Evaluation of a machine learning risk prediction algorithm.
Conclusions: Targeted screening using a ML risk prediction algorithm has the potential to enhance the clinical and cost-effectiveness of AF screening, improving health outcomes through efficient use of limited healthcare resources.
PMID: 31855091 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - December 20, 2019 Category: Health Management Tags: J Med Econ Source Type: research
Use of real-world evidence in meta-analyses and cost-effectiveness models.
The objectives of this communication were to (1) summarise all guidance on how to conduct an RWE meta-analysis (MA) and how to develop an RWE cost-effectiveness model, (2) to describe our experience, challenges faced and solutions identified, (3) to provide recommendations on how to conduct such analyses.No formal guidelines on how to conduct an RWE MA or to develop an RWE cost-effectiveness model were identified. Using the context of non-vitamin K antagonist oral anticoagulants (NOACs) in stroke prevention in atrial fibrillation, we conducted an RWE MA, after having identified sources of uncertainty. We then implemented t...
Source: Journal of Medical Economics - July 14, 2020 Category: Health Management Tags: J Med Econ Source Type: research
Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the U.S.
Conclusions: A substantial portion of hospitalized AF patients did not receive any AC therapy, particularly those patients with an AF diagnosis in the second position on hospital records. The predictors of inpatient AC treatment that were identified may be helpful in the clinical decision-making process for patients who are hospitalized with AF.
PMID: 33021129 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - October 8, 2020 Category: Health Management Tags: J Med Econ Source Type: research
CHA(2)DS(2)-VASc and has-BLED scores do not accurately stratify risk for stroke or bleed in fall victims with atrial fibrillation - Carr BW, Wooster ME, Nemani LA, Severance SE, Hartwell JL.
BACKGROUND: Falls are the leading cause of morbidity and mortality in the elderly. Non-valvular Atrial fibrillation (AF) is present in up to 9% of this group and often requires oral anticoagulation (OAC). The CHA(2)DS(2)-VASc and HAS-BLED scores are valida...
Source: SafetyLit - November 8, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Budget impact analysis of transcatheter aortic valve replacement in low, intermediate, and high-risk patients with severe aortic stenosis in Saudi Arabia
CONCLUSIONS: Payers, providers, and policymakers increasingly turn to results of BIA to inform technologies affordability decisions. TAVR with SAPIEN 3 appears to generate savings vs. SAVR from a budget impact perspective across various surgical risk levels in Saudi Arabia.PMID:34927509 | DOI:10.1080/13696998.2021.2020569
Source: Journal of Medical Economics - December 20, 2021 Category: Health Management Authors: Jo ão L Carapinha Hussain A Al-Omar Faisal Alqoofi Sondos A Samargandy Pascal Candolfi Source Type: research
Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries
Strokes cause an estimated annual health care burden of 170 billion euros across Europe. Atrial fibrillation is one of the major risk factors for stroke and increases the individual risk 4.2-fold. But preventi...
Source: Health Economics Review - February 26, 2022 Category: Health Management Authors: Steffen Wahler, Ralf Birkemeyer, Dimitrios Alexopoulos, Zbigniew Siudak, Alfred M üller and Johann-Matthias von der Schulenburg Tags: Research Source Type: research
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis
CONCLUSION: Adherence improving interventions for NVAF patients on DOACs such as chronic disease co-management and patient education can be cost-saving and cost-effective, within a range of costs that appear reasonable to the Swedish healthcare system.PMID:35997241 | DOI:10.1080/13696998.2022.2116848
Source: Journal of Medical Economics - August 23, 2022 Category: Health Management Authors: C Blomstr öm Lundqvist S Sj älander L A Garcia Rodriguez Ö Åkerborg G Jin A Caleyachetty M Huelsebeck K Bowrin B Schaefer H Mahdessian L Hofmeister L Å Levin Source Type: research
